These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2526722)

  • 1. Suppressor T-cell abnormality in NOD mice before onset of diabetes.
    Hatamori N; Yokono K; Nagata M; Kawase Y; Hayakawa M; Akiyama H; Sakamoto T; Yonezawa K; Yaso S; Shii K
    Diabetes Res Clin Pract; 1989 May; 6(4):265-70. PubMed ID: 2526722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.
    Serreze DV; Leiter EH
    J Immunol; 1988 Jun; 140(11):3801-7. PubMed ID: 2897395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice.
    McInerney MF; Pek SB; Thomas DW
    Diabetes; 1991 Jun; 40(6):715-25. PubMed ID: 2040388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse.
    Yokono K; Kawase Y; Nagata M; Hatamori N; Baba S
    Diabetologia; 1989 Jan; 32(1):67-73. PubMed ID: 2785066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
    Radosevic K; Casteels KM; Mathieu C; Van Ewijk W; Drexhage HA; Leenen PJ
    J Autoimmun; 1999 Dec; 13(4):373-82. PubMed ID: 10585753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired mitogen-induced expression of high-affinity interleukin 2 receptors on spleen cells from NOD/Shi/Kbe mice.
    Hatamori N; Yokono K; Nagata M; Shii K; Baba S
    Diabetes; 1990 Sep; 39(9):1070-8. PubMed ID: 2384189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in the sera from newly diagnosed diabetic nod mice: evidence against cross-reactivity with a putative beta-cell surface autoantigen.
    Formby B; Miller N
    Diabetes Res; 1990 Jan; 13(1):13-7. PubMed ID: 2097091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.
    Miyazaki A; Hanafusa T; Yamada K; Miyagawa J; Fujino-Kurihara H; Nakajima H; Nonaka K; Tarui S
    Clin Exp Immunol; 1985 Jun; 60(3):622-30. PubMed ID: 3160515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the pathogenesis of type I diabetes mellitus--destruction of pancreatic beta cells by cytotoxic T lymphocytes in nonobese diabetic mice].
    Nagata M
    Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):145-58. PubMed ID: 2189754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice.
    Zipris D; Crow AR; Delovitch TL
    Diabetes; 1991 Apr; 40(4):429-35. PubMed ID: 1826279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
    Gregori S; Giarratana N; Smiroldo S; Adorini L
    J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice.
    Yasunami R; Bach JF
    Eur J Immunol; 1988 Mar; 18(3):481-4. PubMed ID: 2965652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
    Rapoport MJ; Jaramillo A; Zipris D; Lazarus AH; Serreze DV; Leiter EH; Cyopick P; Danska JS; Delovitch TL
    J Exp Med; 1993 Jul; 178(1):87-99. PubMed ID: 8315397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD mice with high incidence of type 1 diabetes are not T lymphocytopenic.
    Satoh J; Shintani S; Nobunaga T; Sugawara S; Makino S; Toyota T; Goto Y
    Tohoku J Exp Med; 1988 Jun; 155(2):151-8. PubMed ID: 3264948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.